Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ: ENVB )

2.235 -0.065 (-2.83%)
Streaming Delayed Price Updated: 12:12 PM EST, Feb 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stocks That Hit 52-Week Lows On Friday
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers ContraFect (NASDAQ:CFRX) stock in... 
Via Benzinga
Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021!
Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the... 
Via Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Eloxx Pharmaceuticals (NASDAQ: 
Via Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
Gainers Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO... 
Via Benzinga
Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline
The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
Texas NORML Director Hired To Oversee State Policy Reform Efforts The National Organization for the Reform of Marijuana Laws (N... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Enveric Biosciences' CBD-Based Product Reduces Dermatitis Severity In Animal Study
Enveric Biosciences (NASDAQ: ENVB) announced data from a preclinical rodent model evaluating EV102, the company's cannabidiol (CBD) based product in... 
Via Benzinga
Earnings Scheduled For November 16, 2021
Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million. • Sea (... 
Via Benzinga
EXCLUSIVE: Benzinga Interviews Mind Cure CEO Kelsey Ramsden with Updates on Latest Press Release
Image by: iStock The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored conte... 
Via Benzinga
Bringing Mental Health Pharmacology into the 21st Century: How the Marriage of Enveric Biosciences and MagicMed Industries Could Revolutionize the Way We Treat Mental Health
Photo by Christina Victoria Craft on Unsplash The world is finally waking up to the importance of mental health. It is becoming more acceptable to talk about mental illness.... 
Via Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
The Week In Psychedelics 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ocugen (NASDAQ:OCGN) shares moved upwards by 11.11% to $7.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.4... 
Via Benzinga
September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances
Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
Via Talk Markets
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference
The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth. ... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers OptimizeRx (NASDAQ:OPRX) stock increased by 12.12% to $84.05 during Thursday's pre-market session. The company's market cap stands at $1.4 billion.... 
Via Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
Gainers Superior Drilling Products, Inc. (NYSE: SDPI) rose 58.7% to $1.73 in pre-market trading after jumping over 23% on Wednesday. The company, last month, reported Q2... 
Via Benzinga
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September
Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF On Thursday, AdvisorShares 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million.... 
Via Benzinga
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
The psychedelics sector has closed one of its largest M&As since its inception. 
Via Talk Markets
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
The psychedelics sector has closed one of its largest M&As since its inception. On Friday, Enveric Biosciences (NASDAQ: 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead... 
Via Benzinga
Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week
The performance of the psychedelic-focused index components substantially outshone the weed stocks. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
48 Biggest Movers From Yesterday
Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy... 
Via Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Impel NeuroPharma (NASDAQ:IMPL) shares increased by 22.16% to $20.29 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.1... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.